ADC Therapeutics 주식 가격. ADCT - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

개인 투자자를 위한 전문가급 도구.

프리미엄

가격

2.00

매수가

매도가

거래량

100

0.00 일간 변동폭 0.00

0.684 52주 범위 6.04

market_cap

193.379M

전일 종가

1.98

개장가

최근 거래 시간

100

(formt)

마지막 거래 시간

18:42:47

재정 규모

VWAP

평균 볼륨(3m)

371,779

발행 주식

96,689,617

배당수익률

주가수익률

-0.82

주당순이익(EPS)

-2.43

매출

69.56M

순이익

-234.53M

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602,... ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212. 더 보기

섹터

Drugs And Proprietary-whsl

산업

Drugs And Proprietary-whsl

웹사이트

www.adctherapeutics.com

본부

Lausanne, Che

설립됨

ADC Therapeutics SA is listed in the Drugs And Proprietary-whsl sector of the 뉴욕 증권거래소 with ticker ADCT. The last closing price for ADC Therapeutics was US$1.98. Over the last year, ADC Therapeutics shares have traded in a share price range of US$ 0.684 to US$ 6.04.

ADC Therapeutics currently has 96,689,617 shares in issue. The market capitalisation of ADC Therapeutics is US$191.45 million. ADC Therapeutics has a price to earnings ratio (PE ratio) of -0.82.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update

ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update PR Newswire LAUSANNE, Switzerland, Nov. 7, 2024 LOTIS-5 full enrollment and LOTIS-7...

ADC Therapeutics Announces Investigator-Initiated Study Abstracts Accepted for Presentation at the 66th ASH Annual Meeting

ADC Therapeutics Announces Investigator-Initiated Study Abstracts Accepted for Presentation at the 66th ASH Annual Meeting PR Newswire LAUSANNE, Switzerland, Nov. 5, 2024 Oral presentation of...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-0.835	-29.4532627866	2.835	2.84	1.885	480131	2.23832089	CS
4	-0.95	-32.2033898305	2.95	3.3	1.885	424763	2.76378034	CS
12	-0.98	-32.8859060403	2.98	3.45	1.885	371779	2.94034048	CS
26	-2.1	-51.2195121951	4.1	4.17	1.885	546697	3.15054261	CS
52	1.3	185.714285714	0.7	6.04	0.684	644502	3.2205406	CS
156	-20.83	-91.2395970215	22.83	23.2832	0.359908	482306	4.01598337	CS
260	-28	-93.3333333333	30	56.5899	0.359908	405351	9.57564414	CS

가장 활성
% 상승자
% 패자

기호	가격	볼륨
SNDASonida Senior Living	US$ 33.00 (38.83%)	3
SNOWSnowflake Inc	US$ 155.60 (20.51%)	207.01k
OBKOrigin Bancorp Inc	US$ 39.98 (18.11%)	5
PLOWDouglas Dynamics Inc	US$ 29.00 (18.03%)	4
UHTUniversal Health Realty Income Trust	US$ 46.73 (16.33%)	2
SMPStandard Motor Products Inc	US$ 20.00 (-36.67%)	102
SDHCSmith Douglas Homes Corp	US$ 21.00 (-32.78%)	103
WSWorthington Steel Inc	US$ 35.22 (-19.86%)	104
STELStellar Bancorp Inc	US$ 23.61 (-19.64%)	104
NPKNational Presto Industries Inc	US$ 62.30 (-17.54%)	204
NIONIO Inc	US$ 4.57 (-1.72%)	213.26k
SNOWSnowflake Inc	US$ 155.60 (20.51%)	207.01k
IONQIonQ Inc	US$ 28.06 (-2.77%)	167.03k
PLTRPalantir Technologies Inc	US$ 61.35 (-1.24%)	149.34k
ZETAZeta Global Holdings Corp	US$ 23.34 (1.00%)	141.55k